Maxillary Sinus
Conditions
Interventions
This is a randomized, controlled clinical trial in a parallel and single-blind model. The evaluating researcher will not know which group the patient belongs. Thirty-six patients will be involved in t
2) PBMT Group: Irradiation of the grafted area with laser at red and infrared wavelengths in the baseline periods, 3 and 7 days after the surgical procedure
3) i-PRF Group: Association of deproteinized bovine bone with i-PRF. Patients will be submit the the surgical procedure of sinus floor augumentation associated with ther gratinf procedure. After 4 mon
E02.594
D12.776.124.270
Sponsors
Universidade Federal de Uberlândia
Universidade Federal de Uberlândia
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The patient required to present between 18 and 60 years old, need unilateral or bilateral elevation of the floor of the maxillary sinus for subsequent installation of osseointegrated implants. present bone availability associated with the alveolar ridge adjacent to the maxillary sinus less than or equal to 3mm. present good systemic health. present at least less than 4 months of healing of the socket after tooth extraction
Exclusion criteria
Exclusion criteria: Smokers. decompensated diabetics. patients with chronic or aggressive periodontitis. patients who use drugs that alter bone metabolism. patients who have chronic infections of the upper airways. patients who chronically use anti-inflammatory drugs and antibiotics, people with bruxism, alcoholics, drug addicts. pregnant women or those who wish to become pregnant in the next year. history of radiotherapy treatment in the head and neck region, patients with pathologies that affect bone metabolism. patients who have had a large rupture of the membrane during surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dual wavelength laser therapy and fibrin-based blood concentrate will increase bone formation by 15% in maxillary sinuses grafted with deproteinated bovine bone compared to the use of this bone substitute alone. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dual-wavelength laser therapy and fibrin-based blood concentrate will increase the volume of grafted area by 10% in maxillary sinuses grafted with deproteinized bovine bone compared to the use of this bone substitute alone.;Implants installed in the posterior region of the maxilla previously grafted with deproteinized bovine bone that were treated with dual-wavelength laser therapy or with fibrin-based blood concentrate will increase the success of implants by 10% compared to the use of this bone substitute alone. | — |
Countries
Brazil
Contacts
Public ContactGuilherme Oliveira
Universidade Federal de Uberlândia
Outcome results
None listed